Large Cap Biopharma Stalled With Move to Small Caps and Reflation Trade
February 15, 2021 at 19:29 PM EST
Defensive large-cap biopharma stocks stalled as traders moved out on the risk curve seeking faster gains.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|